« Previous
Next »
Best Practice & Research Clinical Haematology
Volume 20, Issue 1
, Pages 13-18
, March 2007
The leukemic stem cell
References
- . Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine. 1997;3:730–737
- . The molecular basis of leukemia. Hematology/The Education Program of the American Society of Hematology. 2004;80–97
- . Drug therapy for acute myeloid leukemia. Blood. 2005;106:1154–1163
- . New strategies for the treatment of acute myeloid leukemia including antibodies and other novel agents. Hematology/The Education Program of the American Society of Hematology. 2005;143–150
- . New chemotherapeutic agents in acute myeloid leukemia. Leukemia. 1996;10(supplement 1):S4–S6
- Characterization of ARC-111 as a novel topoisomerase I-targeting anticancer drug. Cancer Research. 2003;63:8400–8407
- . Specific targeted therapy of chronic myelogenous leukemia with imatinib. Pharmacological Reviews. 2003;55:401–423
- Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia. Blood. 2004;103:3669–3676
- Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood. 2003;102:972–980
- Preferential induction of apoptosis for primary human leukemic stem cells. Proceedings of the National Academy of Sciences of the USA. 2002;99:16220–16225
- The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood. 2005;105:4163–4169
PII: S1521-6926(06)00074-0
doi: 10.1016/j.beha.2006.10.005
© 2006 Elsevier Ltd. All rights reserved.
« Previous
Next »
Best Practice & Research Clinical Haematology
Volume 20, Issue 1
, Pages 13-18
, March 2007
